WALTHAM, Mass. and BOULDER, Colo., Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COGT), a biotechnology company focused on ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has announced its participation in Guggenheim’s SMID Cap Biotech ...

A replay will be available approximately two hours after the completion of the events and will be archived for up to 30 days. About Cogent Biosciences, Inc. Cogent Biosciences is a biotechnology ...

New York-based VJ Group announced the launch of its newest venture, VJ Bio, a biotech company dedicated to creating an ...

Take a look back at the biggest stories of the week with Fierce Biotech’s conference's kickoff coverage here and the full lowdown from Day 2 here. Check out all the latest news below ...

today announced that management will participate in the Guggenheim SMID Cap Biotech Conference, taking place February 5-6, 2025, in New York City. Management will be participating in one-on-one ...

plans to participate in a fireside chat during the Guggenheim SMID Cap Biotech conference on Thursday, February 6, 2025, at 2:30 p.m. ET in New York. A live webcast will be available in the ...

(Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company dedicated to developing transformative therapies for rare diseases with serious unmet needs, today announced that ...

The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...